(Q36445428)

14 August 2017

1 reference

title

Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain (English)

1 reference

14 August 2017

0 references

Charles E Argoff

1

1 reference

14 August 2017

Misha-Miroslav Backonja

2

1 reference

14 August 2017

Miles J Belgrade

3

1 reference

14 August 2017

Gary J Bennett

4

1 reference

14 August 2017

Michael R Clark

5

1 reference

14 August 2017

B Eliot Cole

6

1 reference

14 August 2017

David A Fishbain

7

1 reference

14 August 2017

Gordon A Irving

8

1 reference

14 August 2017

Bill H McCarberg

9

1 reference

14 August 2017

Michael J McLean

10

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

81

1 reference

14 August 2017

S12-25

1 reference

14 August 2017

4 Suppl

1 reference

Clinical characteristics and economic costs of patients with painful neuropathic disorders

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Duloxetine vs. placebo in patients with painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

A systematic review of antidepressants in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Antidepressants for neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Cyclic antidepressants and the risk of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961475-4

7 January 2021

10.1016/S0025-6196(11)61475-4

Identifiers

DOI

0 references

1 reference